Toggle navigation
Home
Search
Services
Blog
Contact
About
Therapeutic Tumor Vaccine Against MUC-1
Grabstein, Kenneth H.
Corixa Corporation, Hamilton, WA, United States
Search grants from Kenneth Grabstein
Search grants from Corixa Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Differential regulation of protrusive activity during collective cell migration
Investigating the biology of lysine succinylation
Uptake of STAR: Increasing Qualified Staff to improve care of older adults in Ass
In vivo imaging of enzyme activity
Steroid Alpha-Reductase - Mapping the Substrate Binding
Recently added grants:
Small RNAs and telomere biology
PED Screen: Pediatric Sepsis EHR Registry, Clinical Outcomes, and Predictive Model
Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
Boston University Conference on Language Development
Early Environment, Developmental Epigenetics, and Adult Colonic Diseases
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA069969-01
Application #
2113926
Study Section
Special Emphasis Panel (ZRG7-SSS-4 (02))
Project Start
1996-05-24
Project End
1996-11-23
Budget Start
1996-05-24
Budget End
1996-11-23
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Corixa Corporation
Department
Type
DUNS #
City
Hamilton
State
WA
Country
United States
Zip Code
Comments
Be the first to comment on Kenneth Grabstein's grant